Pigmentary Glaucoma
Definition
A secondary open-angle glaucoma resulting from trabecular meshwork obstruction by pigment granules liberated in pigment dispersion syndrome, leading to elevated IOP and progressive optic neuropathy.
Clinical Snapshot
Pigmentary glaucoma is the glaucomatous complication of pigment dispersion syndrome — it develops when trabecular meshwork pigment accumulation causes sufficient outflow obstruction to produce elevated IOP and glaucomatous optic nerve damage. It presents in younger patients than POAG (typically 20–45 years), and the long life expectancy of affected individuals makes aggressive IOP management essential to prevent lifetime vision loss.
Epidemiology
Approximately 35% of PDS patients develop pigmentary glaucoma over 15 years. It predominantly affects young myopic males. The conversion rate is higher in males and in patients with higher IOP at diagnosis.
Pathophysiology
Pigment granules accumulate in the trabecular meshwork, physically obstructing aqueous outflow and causing IOP elevation. Over time, trabecular meshwork cells phagocytose pigment and may undergo apoptosis, further reducing outflow facility. The resulting IOP elevation produces glaucomatous optic nerve damage through the same mechanisms as POAG.
Risk Factors
- Pigment dispersion syndrome (prerequisite)
- Male sex
- Higher IOP at PDS diagnosis
- Younger age at PDS diagnosis
- Myopia
Clinical Presentation
Identical to POAG in terms of optic nerve and visual field findings, but occurring in younger patients. The anterior segment findings of PDS (Krukenberg spindle, iris transillumination defects, trabecular meshwork pigmentation) are present. IOP is elevated.
Diagnostic Pearls
- Pigmentary glaucoma in a young myopic male should be recognized as a distinct entity from POAG — the management implications (aggressive IOP control, long treatment duration) differ.
- Gonioscopy confirms the diagnosis — dense trabecular meshwork pigmentation is the hallmark.
- Exercise-induced IOP spikes may cause acute visual symptoms — counsel patients accordingly.
Differential Diagnosis
- Primary open-angle glaucoma
- Pseudoexfoliation glaucoma
- Uveitic glaucoma
Evidence-Based Management
Aggressive IOP lowering is the goal — the long life expectancy of young patients with pigmentary glaucoma means that even slow progression will cause significant cumulative damage. Prostaglandin analogues are first-line. Laser trabeculoplasty is effective but may cause IOP spikes in heavily pigmented angles — use with caution. Surgical intervention (trabeculectomy, MIGS) is appropriate for inadequate IOP control on maximal medical therapy.
Monitoring & Follow-Up
More frequent monitoring than POAG is appropriate given the younger age and longer expected treatment duration. Annual visual fields and OCT RNFL are standard.
Clinical Pearls
- Young patients with pigmentary glaucoma have decades of disease ahead — aggressive IOP targets are justified.
- The pigment burden may decrease with age as iris-zonule contact diminishes — some patients experience spontaneous IOP reduction over time.
- Laser trabeculoplasty requires careful IOP monitoring post-procedure in heavily pigmented angles.
- Counsel patients about the exercise-IOP relationship — vigorous exercise may cause transient IOP spikes.
Related Therapeutics — Clinician's Companion
- Glaucoma Therapeutics — Prostaglandins, Beta-blockers (Clinician's Companion)
Key References
- 1.Ritch R, et al. Pigment dispersion syndrome. Surv Ophthalmol. 1996.
- 2.Migdal C. Pigmentary glaucoma. Br J Ophthalmol. 1994.
This entry is an educational reference designed to support clinical reasoning and awareness. It does not constitute medical advice, establish a standard of care, or replace individualized patient assessment. Clinicians should consult current guidelines and applicable clinical resources when making patient care decisions.